hg_166204.1

Basic information about the TSS

---

TSS ID: hg_166204.1 Species: human Chr: chr17		Start: 43015681 End: 43015834 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: LF327931 MA563508 Distance: 105 GeneID: 10493 HGNC/MGI_ID: HGNC:16919 UniProt_ID: K7EJM4

Gene_name: VAT1 Gene_symbol: VAT1 Gene_synonyms: FLJ20230 VATI Gene_source: HGNC:16919

TATA-Box annotation

---

Distance to TSS:	6627
Nearest PromoterID:	NM_006373
Entrez ID:	10493
Nearest Unigene:	Hs.514199
Nearest Refseq:	NM_006373
Nearest Ensembl:	ENSG00000108828
Gene Name:	VAT1
Gene Alias:	VATI
Gene Description:	vesicle amine transport 1
Gene Type:	protein-coding
CpG%:	0.03
GC%:	0.626866
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@VAT1 p2@VAT1 p3@VAT1 p6@VAT1 p7@VAT1 p8@VAT1
Sample		p1@VAT1	p2@VAT1	p3@VAT1	p6@VAT1	p7@VAT1	p8@VAT1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	48.12	5.26	2.53	0.58	0.39	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	55.44	7.49	2.43	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	56.14	5.21	3.28	0.19	0.77	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	67.15	6.03	2.08	0.42	0.83	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	63.44	2.70	2.25	0.22	0.45	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	52.72	5.23	1.94	0.78	0.97	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	73.86	4.36	2.61	0.44	0.65	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	55.47	5.81	3.15	0.48	0.73	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	71.81	5.34	3.42	0.43	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	71.29	2.32	2.32	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	57.81	2.02	2.83	0.40	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	60.58	2.44	2.85	0.81	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	140.72	49.81	1.93	0.64	0.81	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	112.61	32.78	1.50	1.65	0.75	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	132.83	40.62	0.22	1.10	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	139.83	41.50	1.01	1.76	0.00	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	143.06	41.93	0.87	0.66	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	133.72	27.42	1.27	0.42	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	125.29	28.26	0.53	1.07	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	107.42	30.24	2.26	0.60	1.05	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	111.33	32.74	1.20	0.53	0.80	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	92.87	29.86	1.21	1.21	0.69	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	102.89	32.44	1.29	0.90	1.29	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	121.09	32.76	1.46	1.21	1.70	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	127.96	35.86	2.84	0.52	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	115.84	35.13	2.22	0.63	0.95	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	105.50	26.37	2.20	1.65	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	112.45	31.59	1.18	1.41	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	95.94	26.65	1.45	0.81	0.65	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	109.30	32.21	1.27	0.90	0.54	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	112.84	28.89	2.51	0.84	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	115.67	28.53	0.98	0.59	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	102.14	26.38	1.27	1.06	0.84	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	76.37	16.99	0.49	0.99	0.49	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	109.01	29.73	1.50	0.37	0.56	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	111.14	36.03	1.72	0.96	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	100.76	27.18	0.41	1.02	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	106.79	28.01	0.81	0.60	1.21	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	116.14	29.98	0.81	1.08	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	108.99	24.01	2.40	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	105.40	27.29	0.71	0.47	1.18	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	75.10	19.32	0.73	0.73	1.02	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	112.83	28.05	1.05	0.42	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	116.61	30.94	1.92	0.35	0.35	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	107.61	29.51	0.60	0.80	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	112.37	28.38	0.93	0.93	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	117.07	34.55	0.24	0.72	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	106.70	28.91	2.09	0.60	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	116.34	33.75	1.91	0.24	0.24	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	94.63	25.88	1.01	0.61	1.42	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	94.07	23.16	0.61	1.02	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	100.96	27.13	2.67	1.33	1.11	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	0.00	0.00	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	108.59	32.29	0.35	1.06	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	89.81	23.53	1.33	1.33	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	17.62	5.87	0.84	2.52	0.84	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	31.23	6.43	0.46	1.38	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	91.72	32.09	0.97	0.65	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	109.20	25.05	0.96	1.28	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	43.38	7.86	0.94	1.57	0.63	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	64.86	21.86	0.00	1.41	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	56.64	15.14	0.56	0.00	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	21.50	4.78	0.80	2.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	24.80	5.10	0.34	0.34	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	66.28	19.17	1.62	0.00	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	51.83	11.71	0.35	0.35	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	28.76	12.19	0.98	0.49	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	29.75	9.92	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	9.38	0.47	0.00	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.24	5.63	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	27.84	10.21	0.00	0.62	0.62	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.49	11.31	0.61	0.00	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	314.08	11.40	12.51	1.43	1.74	0.95
Adipocyte - breast, donor2	11327-117E4	236.15	10.91	5.61	4.49	2.09	0.96
Adipocyte - omental, donor1	11473-119C6	181.30	10.05	7.63	0.76	1.02	0.51
Adipocyte - omental, donor2	11474-119C7	196.59	11.21	8.22	3.74	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	138.32	8.04	5.02	1.00	0.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	115.48	3.83	0.64	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	78.06	0.00	2.20	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	172.97	8.58	6.77	0.90	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	120.08	7.12	2.61	0.35	0.52	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	204.37	15.45	5.28	0.59	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	189.17	13.38	2.83	0.26	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	394.46	16.17	6.41	0.28	1.12	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	302.72	15.87	9.99	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	227.30	12.79	8.61	0.97	0.64	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	334.05	19.04	6.13	0.65	0.65	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	390.83	11.20	10.13	4.27	3.73	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	366.14	12.24	11.13	0.56	1.67	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	410.49	10.40	14.97	2.91	0.00	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	337.32	15.32	10.05	0.50	1.51	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	394.98	16.69	13.42	1.31	1.31	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	390.64	12.79	13.09	0.91	1.52	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	195.36	15.69	7.96	0.00	0.66	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	301.93	30.12	9.68	1.79	2.51	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	179.70	9.58	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	51.27	8.82	0.90	0.18	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	71.96	18.41	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	131.28	20.75	2.67	0.41	0.21	0.82
Anulus Pulposus Cell, donor1	11248-116E6	285.84	25.63	5.95	1.03	1.37	0.69
Anulus Pulposus Cell, donor2	11463-119B5	207.19	17.39	4.90	0.73	1.22	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	214.76	19.32	11.23	3.59	1.80	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	255.71	13.46	15.19	5.21	4.78	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	233.29	23.54	10.70	8.56	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	246.91	11.96	12.55	5.68	1.79	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	252.93	7.59	16.44	10.12	1.26	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	264.69	15.18	11.22	5.28	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	240.42	8.45	13.32	4.22	0.65	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	236.41	13.59	15.53	3.40	4.37	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	276.75	11.88	17.82	2.38	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	228.62	13.56	10.55	3.39	2.26	3.77
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	221.33	13.79	13.06	2.90	2.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	231.95	7.52	18.81	1.25	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	306.08	17.79	19.27	0.82	0.99	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	257.95	5.46	28.66	2.73	2.73	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	207.04	11.46	14.02	1.06	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	250.75	16.07	13.93	3.21	2.14	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	231.82	14.17	12.28	2.83	1.70	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	310.05	15.50	11.49	3.21	4.28	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	261.42	14.63	15.61	3.90	2.93	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	212.80	9.95	14.76	1.99	1.49	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	304.98	13.21	7.20	0.00	4.80	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	219.49	7.08	17.70	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	246.66	11.66	12.86	2.74	1.54	2.57
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	352.38	4.19	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	257.76	9.22	17.48	4.37	3.88	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	240.19	12.90	14.42	1.14	1.90	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	277.40	12.11	8.48	7.27	2.42	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	215.47	7.98	16.53	2.85	3.99	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	254.61	13.25	10.26	1.50	1.50	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	265.57	14.71	11.87	2.32	1.29	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	236.95	18.30	11.73	2.82	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	256.60	12.86	18.65	1.93	2.57	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	250.42	14.98	12.84	3.57	0.71	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	203.56	11.70	12.87	2.92	1.17	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	255.61	14.15	12.65	2.71	1.51	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	308.88	22.57	16.63	0.00	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	226.31	16.78	16.27	3.56	1.53	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	217.76	12.23	9.68	1.78	1.27	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	228.10	14.61	9.53	1.27	0.64	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	229.58	14.67	13.38	2.59	2.59	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	211.05	14.82	10.80	1.69	1.27	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	237.49	15.37	11.31	1.16	1.45	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	248.47	8.50	12.28	1.89	0.94	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	205.63	12.54	12.04	1.36	1.19	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	305.76	20.85	6.95	2.32	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	335.90	8.45	23.24	2.11	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	221.70	15.22	11.36	2.36	2.14	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	333.92	12.63	10.83	4.81	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	220.88	10.21	13.12	5.83	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	254.02	15.63	14.25	1.61	2.07	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	311.14	12.75	12.75	5.10	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	230.33	9.15	15.76	1.78	1.53	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	246.49	11.77	15.69	1.24	0.83	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	274.48	14.69	9.49	1.53	2.14	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	217.02	10.99	15.30	5.26	2.39	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	248.35	13.30	13.53	2.22	2.44	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	228.87	10.68	4.58	1.53	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	160.63	11.63	13.29	2.77	3.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	233.02	11.92	12.71	1.85	1.85	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	229.34	11.63	12.36	2.18	3.27	1.09
Astrocyte - cerebellum, donor1	11500-119F6	141.73	28.25	9.33	0.25	0.12	0.49
Astrocyte - cerebellum, donor2	11580-120F5	136.76	28.07	3.42	1.03	1.03	0.68
Astrocyte - cerebellum, donor3	11661-122F5	98.79	22.44	3.78	0.63	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	67.28	22.31	2.44	0.35	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	83.64	26.21	2.75	0.81	0.65	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	63.54	26.40	2.09	0.45	1.19	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	6.42	7.45	0.00	0.11	0.11	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5.76	5.01	0.00	0.13	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.46	4.55	0.00	0.00	0.00	0.11
Basophils, donor1	12241-129G9	10.20	5.49	0.00	0.00	0.00	0.26
Basophils, donor2	12242-129H1	11.91	3.61	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	11.76	2.65	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	98.96	10.78	2.59	0.43	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	223.56	20.12	2.74	1.37	0.91	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	14.35	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	121.76	10.67	3.77	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	163.45	20.38	4.78	0.83	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	126.66	11.05	2.07	0.69	0.46	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	51.10	7.56	0.72	0.36	1.08	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.33	3.09	0.10	0.00	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.19	3.03	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	70.03	14.07	0.00	0.00	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.14	2.82	0.56	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	9.47	3.34	0.00	0.00	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	12.95	4.83	0.22	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	492.78	33.97	15.00	0.85	1.42	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	479.53	26.16	16.68	0.76	2.27	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	503.63	42.08	11.51	1.31	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	50.45	5.06	0.14	1.01	0.43	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	35.91	4.53	0.60	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	36.72	4.50	0.47	0.47	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.47	4.02	0.17	0.17	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	20.70	4.42	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.31	1.74	0.00	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	20.75	2.15	0.00	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.20	3.38	0.00	0.18	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	11.10	1.09	0.00	0.87	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.22	2.34	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	11.62	2.64	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	13.31	2.22	0.00	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	36.59	4.02	0.30	0.15	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	26.94	2.59	0.60	0.00	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.91	2.08	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	18.53	3.20	0.23	0.23	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	10.86	2.94	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	8.29	0.87	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	31.20	2.42	0.27	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	21.11	5.23	0.17	0.17	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	18.94	0.42	1.26	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	16.35	2.02	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.51	2.11	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.46	2.19	0.00	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.92	1.57	0.35	0.00	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.75	4.09	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	13.58	3.66	0.00	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	21.29	1.64	0.00	0.00	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.03	1.62	0.00	0.23	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.82	1.16	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	8.28	1.96	0.00	0.22	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	9.24	2.54	0.00	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	9.10	2.60	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	17.91	4.05	0.00	0.47	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	18.69	4.02	0.17	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	12.26	4.46	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	4.59	1.28	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.29	2.63	0.00	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	3.79	1.47	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	12.19	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.31	10.85	0.68	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	15.53	14.50	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	27.72	11.73	2.67	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	17.69	15.01	0.00	0.00	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	10.53	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	11.77	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	17.14	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	10.68	13.97	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.78	5.80	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	18.68	12.12	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	22.22	3.64	0.00	0.00	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	19.18	3.60	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	39.16	11.04	3.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	29.21	5.62	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	63.13	15.78	0.00	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	65.84	13.08	0.68	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	11.07	8.57	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	12.86	15.31	0.00	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	13.72	7.93	0.00	0.30	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	7.40	5.62	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	13.03	9.21	0.00	0.22	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	11.21	10.92	0.00	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	11.85	11.38	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	10.53	12.64	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	9.89	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	5.93	5.49	0.00	0.29	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	11.18	7.46	0.00	0.34	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	9.83	6.93	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	14.35	12.55	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	15.37	9.43	0.00	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	9.68	5.28	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8.85	5.48	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	9.77	5.82	0.00	0.21	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.37	9.02	0.00	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	15.23	14.14	0.00	0.27	0.82	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	10.72	16.08	0.00	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	10.76	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	8.90	4.82	0.00	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	10.18	3.90	0.00	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	7.78	6.30	0.00	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	10.11	9.61	0.51	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	12.56	6.07	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	9.59	8.28	0.00	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	16.83	15.84	0.00	0.99	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	9.23	7.39	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	12.56	6.98	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	12.74	6.65	0.28	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	19.39	10.31	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	10.78	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.83	8.24	0.00	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	5.54	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	9.17	6.55	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	7.88	8.26	0.38	0.00	0.00	0.75
CD8+ T Cells, donor3	11383-118B6	12.88	9.85	0.00	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.03	4.82	0.00	0.00	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	12.94	4.79	0.24	0.48	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.68	3.28	0.00	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.11	3.30	0.30	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.76	4.80	0.48	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.19	4.09	0.00	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.91	3.91	0.22	0.22	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.32	5.00	0.26	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.27	3.28	0.23	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.04	2.42	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8.42	4.65	0.29	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.46	3.20	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.44	3.06	0.44	0.00	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.03	2.28	0.46	0.00	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	2.98	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.16	5.76	0.36	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.63	5.75	0.29	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	6.84	4.95	0.47	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.34	4.44	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	9.84	2.46	0.31	0.00	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	9.94	5.13	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.88	4.59	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.06	1.58	0.39	0.00	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.05	3.03	0.00	0.00	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.82	3.21	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.19	3.50	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	4.01	3.01	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	80.42	16.45	9.14	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	372.54	15.81	14.82	0.99	2.96	0.99
Cardiac Myocyte, donor3	11686-122I3	143.01	12.94	7.26	0.32	0.42	0.95
Chondrocyte - de diff, donor1	11261-116G1	227.41	11.09	11.09	1.04	0.35	1.04
Chondrocyte - de diff, donor2	11338-117F6	203.99	11.73	6.04	0.71	1.07	0.36
Chondrocyte - de diff, donor3	11410-118E6	217.32	13.99	5.35	1.37	1.14	1.02
Chondrocyte - re diff, donor2	11339-117F7	68.04	5.37	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	111.62	10.92	2.83	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	137.14	28.12	8.03	1.03	0.80	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	125.91	29.71	7.27	1.28	1.50	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	110.98	25.13	6.99	0.62	1.06	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	134.80	25.31	5.59	0.83	0.83	0.46
Corneal Epithelial Cells, donor1	11526-119I5	108.47	17.57	3.29	0.22	0.44	0.44
Corneal Epithelial Cells, donor2	11606-120I4	93.28	9.10	4.55	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	63.40	9.71	1.02	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	229.81	15.85	9.08	0.50	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	210.38	16.40	6.31	0.00	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	82.82	10.35	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	205.83	13.39	6.80	1.94	1.40	1.51
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.52	4.78	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5.22	2.61	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1.45	1.45	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	314.19	29.35	18.18	0.50	0.83	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	279.89	21.71	18.19	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	214.36	18.10	14.14	0.57	0.57	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	375.10	33.03	16.12	0.79	0.79	0.79
Endothelial Cells - Artery, donor1	11264-116G4	345.85	25.02	22.98	2.62	1.45	1.45
Endothelial Cells - Artery, donor2	11341-117F9	354.56	30.59	26.59	1.88	3.53	5.18
Endothelial Cells - Artery, donor3	11413-118E9	281.37	31.73	23.14	2.28	1.58	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	319.84	35.24	26.38	1.33	1.33	2.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	281.14	27.69	26.17	0.30	0.61	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	239.90	20.86	16.91	0.28	0.85	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	396.08	20.21	27.34	1.78	2.08	2.38
Endothelial Cells - Microvascular, donor2	11342-117G1	237.94	11.98	16.66	1.04	0.52	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	353.33	31.62	15.31	2.27	1.99	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	264.48	23.21	17.21	0.40	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	350.64	25.16	25.16	5.24	3.67	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	231.72	27.33	11.43	1.62	1.74	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	199.66	22.16	5.87	0.43	1.09	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	170.37	24.18	3.18	0.61	0.24	0.98
Endothelial Cells - Vein, donor1	11267-116G7	359.45	32.99	15.93	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	366.71	31.43	16.76	1.40	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	396.44	39.25	22.14	0.94	1.73	1.57
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	9.90	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	82.34	10.75	1.71	0.00	0.49	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	108.17	8.32	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	183.50	13.55	4.93	0.00	2.05	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	376.86	14.56	16.86	7.66	8.76	5.15
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	411.90	24.05	11.38	6.83	7.37	5.85
Fibroblast - Aortic Adventitial, donor1	11245-116E3	156.69	15.77	6.91	0.73	1.70	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	342.82	12.28	28.52	1.09	1.09	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	517.01	20.67	25.95	3.90	4.01	3.90
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	282.20	7.90	11.07	1.05	0.79	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	324.89	25.58	12.96	4.65	2.33	2.33
Fibroblast - Cardiac, donor1	11268-116G8	158.77	14.52	5.90	0.91	1.81	0.00
Fibroblast - Cardiac, donor2	11345-117G4	321.37	29.56	12.89	1.52	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	167.34	22.55	10.88	1.58	2.05	1.73
Fibroblast - Cardiac, donor4	11452-119A3	131.55	11.52	3.64	0.61	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	269.42	16.88	9.64	2.03	1.40	1.90
Fibroblast - Cardiac, donor6	11460-119B2	169.48	10.91	3.79	0.45	1.67	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	147.39	8.17	9.92	0.13	0.40	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	140.65	11.22	4.75	0.86	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	168.45	23.44	5.86	0.00	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	226.26	17.99	8.30	0.46	0.23	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	395.69	18.66	10.69	1.02	1.19	2.54
Fibroblast - Dermal, donor1	11269-116G9	302.87	15.26	12.91	1.17	0.70	2.11
Fibroblast - Dermal, donor2	11346-117G5	190.09	16.04	9.43	0.00	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	218.80	17.89	7.25	0.97	1.93	1.93
Fibroblast - Dermal, donor4	11450-119A1	87.84	12.32	2.37	0.79	0.45	0.79
Fibroblast - Dermal, donor5	11454-119A5	83.91	11.34	1.74	0.35	0.35	0.70
Fibroblast - Dermal, donor6	11458-119A9	85.11	11.69	1.62	0.32	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	151.38	13.12	3.96	0.42	0.62	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	298.94	17.29	6.81	2.10	0.79	0.79
Fibroblast - Gingival, donor2	11318-117D4	160.38	19.77	4.22	1.71	2.24	1.19
Fibroblast - Gingival, donor3	11394-118C8	213.29	17.40	5.22	0.97	0.48	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	231.67	19.74	5.19	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	228.71	16.39	5.29	2.47	2.47	2.11
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	114.58	15.12	2.49	0.62	0.94	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	137.93	16.77	3.11	0.41	0.81	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	227.61	27.17	5.29	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	137.62	13.16	2.34	0.29	0.73	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	206.44	13.64	4.77	0.82	0.82	1.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	97.63	9.76	1.32	0.33	0.11	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	298.47	19.08	4.40	0.88	1.61	0.59
Fibroblast - Lung, donor1	11270-116H1	197.11	24.47	4.08	0.00	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	147.72	16.41	2.98	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	185.71	22.16	5.49	1.69	1.69	2.53
Fibroblast - Lymphatic, donor1	11506-119G3	253.24	15.83	6.66	1.67	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	335.67	11.19	12.59	0.00	5.59	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	132.94	16.79	3.36	0.28	0.00	1.12
Fibroblast - Mammary, donor1	11540-120B1	178.22	19.08	5.68	0.00	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	215.69	7.99	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	273.99	35.74	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	153.05	20.76	4.07	0.58	0.78	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	164.88	18.81	4.10	0.76	1.21	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	123.62	10.71	4.59	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	125.17	12.59	5.34	1.14	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	160.37	21.60	4.32	1.62	1.08	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	185.44	18.09	3.71	0.23	0.12	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	156.85	16.47	10.17	0.77	1.11	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	171.29	15.85	4.06	0.20	0.00	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	205.14	17.37	5.35	0.67	0.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	161.31	15.02	3.16	1.19	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	103.99	7.74	3.97	0.79	0.40	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	99.47	11.01	3.55	0.18	0.18	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	146.04	12.22	4.34	0.39	0.59	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	151.63	11.13	6.02	0.30	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	151.24	11.87	5.72	0.76	0.65	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	168.04	9.87	5.57	1.77	0.25	1.27
Fibroblast - skin normal, donor1	11553-120C5	161.12	15.92	6.07	0.82	0.49	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	160.00	15.04	5.41	0.00	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	217.10	14.17	11.65	1.61	1.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	236.65	19.34	6.35	0.60	1.51	2.42
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	179.78	16.32	5.30	0.50	0.50	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	218.82	13.16	6.50	1.03	0.34	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	124.80	11.50	3.28	0.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	115.36	15.98	7.03	0.85	0.75	1.49
Fibroblast - skin walker warburg, donor1	11554-120C6	85.52	13.33	2.19	0.34	0.17	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	113.54	12.39	3.45	3.14	5.18	3.92
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	243.76	22.16	22.16	22.16	66.48	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	131.60	7.84	4.36	2.61	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	264.72	13.18	13.35	0.69	1.21	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	151.46	7.29	7.55	0.00	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	142.06	8.94	4.85	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	306.22	28.33	17.61	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	269.90	28.08	14.68	3.19	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	220.79	27.10	14.55	3.42	1.43	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	373.38	58.74	12.13	0.28	0.83	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	264.86	42.93	7.31	0.46	1.14	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	266.88	41.01	13.87	1.19	0.99	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	387.25	60.00	10.84	0.79	1.06	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	293.21	41.75	3.91	0.33	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	202.10	27.86	9.73	0.88	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	289.15	30.53	16.39	3.96	2.69	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	298.13	32.02	15.64	1.72	3.08	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	323.96	28.21	12.89	2.95	3.49	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	365.36	41.01	17.72	2.97	1.12	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	372.23	46.51	13.98	4.15	2.49	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	334.03	33.14	14.03	3.66	4.07	3.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	453.16	31.26	14.60	1.14	1.60	2.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	518.82	37.37	20.68	5.61	3.99	3.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	504.26	38.91	20.33	1.75	0.66	2.40
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	341.57	26.00	10.64	3.84	2.36	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	321.25	28.45	16.85	3.18	2.70	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	382.72	34.63	14.08	0.89	0.67	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	329.67	27.42	8.47	2.82	2.82	3.63
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	279.74	26.80	15.78	4.41	2.54	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	382.71	26.60	19.60	1.33	0.71	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	502.38	44.64	13.11	0.73	1.14	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	451.36	37.57	13.15	0.68	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	337.72	30.76	12.84	2.21	2.55	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	301.75	22.30	13.98	0.92	0.67	1.41
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	296.67	17.97	16.13	1.43	0.20	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	323.90	28.26	10.52	1.86	2.06	2.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	336.89	34.13	13.03	2.65	1.61	2.19
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	340.87	20.18	15.51	3.17	2.67	2.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	388.62	32.84	9.48	2.65	2.65	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	387.55	31.49	10.70	2.71	3.32	2.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	256.75	22.04	12.48	1.46	0.97	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	419.82	34.00	10.58	3.53	2.25	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	374.09	29.66	15.54	3.22	2.18	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	378.99	24.52	14.71	1.74	3.48	2.06
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	395.92	28.58	16.42	3.34	2.13	2.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	328.56	25.93	13.90	2.30	1.67	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	411.89	30.52	12.95	4.17	3.73	3.73
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	343.95	28.62	12.06	1.40	3.37	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	392.38	21.11	23.05	2.22	0.93	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	475.98	18.45	22.46	2.67	2.94	2.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	431.17	21.88	20.96	1.84	1.84	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	408.43	19.30	30.57	3.11	2.59	1.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	548.92	19.25	24.13	3.25	2.98	3.80
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	382.34	22.31	15.49	3.13	2.58	4.42
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	357.70	19.08	15.35	1.97	1.97	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	733.89	29.75	19.83	1.98	0.00	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	341.78	19.39	15.70	1.32	1.32	1.58
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	300.62	21.79	10.49	2.82	0.00	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	839.74	49.31	28.47	0.51	0.76	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	267.74	18.11	22.10	2.19	1.19	2.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	293.82	28.66	17.56	1.39	1.85	2.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	295.83	24.14	20.25	1.23	1.02	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	174.62	18.78	22.53	0.63	1.25	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	183.66	17.52	16.39	0.85	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	162.34	26.75	9.69	0.46	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	247.48	19.80	12.37	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	208.88	15.09	11.99	1.93	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	250.30	19.25	12.84	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	189.53	17.39	12.17	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	177.06	14.00	8.14	1.30	1.95	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	158.96	9.06	7.00	1.65	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	169.95	23.33	13.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	150.45	12.02	10.07	0.00	1.40	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	166.36	18.63	10.46	0.98	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	141.76	21.81	2.52	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	164.76	14.00	10.81	0.64	1.91	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	144.70	17.32	6.11	0.34	1.36	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	131.55	14.62	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	178.68	20.04	5.15	1.15	0.00	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	162.20	21.01	7.40	0.89	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	128.75	6.78	5.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	131.30	12.43	6.21	1.24	2.90	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	97.11	6.44	5.75	0.69	0.92	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	126.44	10.54	10.54	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	109.56	12.69	5.38	0.77	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	131.69	9.45	2.93	0.98	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	167.21	14.05	7.36	0.67	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	166.82	24.66	3.47	1.93	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	134.88	17.46	3.77	1.03	0.68	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	201.27	32.30	7.45	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	203.84	23.12	2.36	1.42	0.47	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	174.41	19.92	3.62	1.21	2.41	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	184.65	31.03	4.07	0.51	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	136.40	13.56	1.99	1.60	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	152.45	21.21	3.45	1.48	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	177.07	20.07	1.18	3.54	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	187.29	21.00	4.08	0.58	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	196.18	19.31	3.95	3.07	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	132.24	21.19	2.54	2.54	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	99.68	10.15	2.39	1.19	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	95.11	5.82	4.37	0.97	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	123.26	10.27	7.99	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	104.79	16.22	5.82	1.25	0.42	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	156.30	21.36	2.25	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	95.47	6.66	2.85	1.59	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	234.77	6.68	10.44	0.84	1.67	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	96.90	12.42	2.67	1.04	0.58	1.51
Hep-2 cells mock treated, biol_rep2	11899-125E9	101.96	14.18	3.04	1.01	1.35	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	84.63	13.88	1.82	1.37	1.14	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	98.27	16.51	2.73	1.09	1.09	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	118.20	13.97	1.72	1.29	1.29	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	87.40	11.41	2.37	0.43	0.65	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	100.38	13.08	3.24	0.87	1.25	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	103.62	10.64	2.40	1.37	1.37	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	88.42	12.81	0.96	0.96	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	472.32	34.70	13.99	2.24	1.12	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	313.34	32.89	9.95	0.43	1.73	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	423.01	15.86	13.22	7.93	0.00	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	219.75	18.34	11.64	0.35	0.35	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	247.01	26.88	7.99	0.73	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	165.57	8.22	8.04	2.27	1.57	1.57
Hepatocyte, donor1	11523-119I2	25.42	2.42	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	65.72	4.31	5.39	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	65.65	7.36	1.23	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	82.89	24.80	0.65	0.00	0.65	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	166.04	13.46	5.24	0.52	1.05	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	163.69	22.09	12.21	0.14	1.10	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	15.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	133.51	20.03	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	69.22	8.31	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	82.59	22.52	0.00	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	35.60	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	82.01	5.13	2.56	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	91.42	22.85	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	92.59	12.99	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	85.03	20.01	1.67	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	29.04	3.63	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	88.67	15.88	6.62	3.97	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	53.21	18.85	2.22	2.22	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	130.96	26.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	62.99	17.64	1.26	1.26	0.63	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	72.69	9.28	4.64	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	84.63	20.67	2.58	1.29	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	80.50	11.27	1.61	0.00	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	67.63	22.82	4.07	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	96.56	18.89	2.94	0.42	0.42	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	74.74	15.27	0.80	4.02	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	71.09	14.77	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	72.22	17.94	1.42	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	64.40	15.42	1.81	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	72.10	18.29	1.08	1.08	2.15	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	81.31	11.43	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	79.07	17.22	3.83	0.00	0.00	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	78.37	30.99	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	100.68	17.85	3.57	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	76.32	23.23	6.64	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	71.30	16.05	1.85	0.93	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	64.97	21.07	1.76	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	9.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	76.49	20.86	0.70	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	123.93	22.13	2.21	2.21	4.43	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	74.57	22.69	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	117.71	26.16	3.49	1.74	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	110.24	13.50	4.50	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	118.48	52.27	3.48	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	123.75	22.40	2.13	1.07	0.00	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	76.20	13.85	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	71.24	17.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	110.45	27.61	3.68	1.84	1.84	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	160.34	12.10	9.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	136.59	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	182.93	37.01	5.29	1.06	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	295.39	16.24	12.57	0.65	0.82	1.71
Keratinocyte - epidermal, donor2	11349-117G8	79.06	12.30	2.34	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	53.76	12.49	0.47	0.28	0.38	0.38
Keratinocyte - oral, donor1	11251-116E9	111.25	19.75	2.38	1.25	0.91	1.82
Keratocytes, donor1	11527-119I6	379.25	25.79	16.85	1.03	0.69	0.69
Keratocytes, donor2	11607-120I5	251.94	23.44	4.69	0.00	1.17	1.17
Keratocytes, donor3	11688-122I5	261.42	13.04	4.54	1.19	0.99	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	90.61	30.20	6.47	1.08	4.31	3.24
Lens Epithelial Cells, donor2	11609-120I7	203.10	40.94	8.30	0.69	0.69	0.58
Lens Epithelial Cells, donor3	11690-122I7	118.57	14.03	10.60	0.00	0.20	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	228.73	19.45	13.52	0.83	1.19	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	202.61	13.67	7.26	0.28	0.56	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	228.40	18.89	8.34	0.94	1.42	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	175.30	18.28	8.07	1.08	3.23	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	212.11	13.87	10.40	1.26	1.89	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	223.28	17.57	11.54	1.08	1.40	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	171.54	15.59	6.98	0.41	0.82	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	251.05	19.21	8.85	1.77	1.77	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	226.33	15.20	12.10	0.42	1.13	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	188.67	8.70	9.10	1.19	1.58	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	206.10	18.03	6.01	0.00	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	260.69	21.11	11.48	0.19	0.93	1.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	195.12	12.89	8.71	1.39	2.09	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	231.61	20.51	10.50	0.48	0.72	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	226.62	17.17	10.71	1.10	1.24	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	218.96	20.63	7.70	0.31	1.54	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	233.81	15.59	11.85	0.31	0.94	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	264.24	15.55	11.53	0.73	0.91	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	173.44	19.42	8.56	0.66	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	237.52	18.16	9.37	0.29	0.59	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	294.23	18.42	11.45	1.49	1.99	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	193.02	15.52	7.76	0.00	0.48	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	208.44	16.16	5.92	0.54	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	229.79	17.71	11.20	1.51	0.91	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	191.29	15.03	8.29	0.52	2.59	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	212.53	17.17	9.84	0.84	0.63	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	230.97	17.44	11.58	1.65	0.90	1.35
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	235.94	19.95	11.01	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	233.87	12.98	8.47	0.94	0.94	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	252.56	19.30	10.71	0.95	0.53	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	234.05	21.32	8.72	2.91	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	253.38	14.89	10.25	1.65	1.32	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	268.47	20.19	11.15	1.49	1.24	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	243.60	14.44	7.03	0.00	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	208.78	20.01	6.18	0.49	2.22	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	256.98	20.62	12.10	1.37	0.96	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	222.25	17.69	8.68	0.64	0.96	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	255.64	16.13	8.83	0.61	0.61	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	243.82	20.02	12.74	0.84	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	201.96	17.07	8.53	0.71	1.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	291.35	17.45	9.70	0.00	1.45	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	301.57	21.94	10.58	0.62	0.93	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	236.35	21.13	7.16	2.15	1.07	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	250.89	17.97	11.76	0.65	0.98	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	270.50	17.19	12.24	1.65	1.65	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	267.80	23.14	11.39	0.25	1.61	1.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	291.99	22.03	9.73	0.00	1.02	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	189.46	14.62	6.86	0.90	1.19	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	6.80	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	72.11	5.37	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	72.74	5.94	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	89.70	9.31	1.27	0.85	2.12	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	56.97	6.33	0.70	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	65.38	4.67	0.00	0.00	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	73.68	7.21	2.06	2.06	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	65.42	8.33	0.00	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	71.25	8.82	1.81	0.90	0.68	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	61.95	5.82	0.87	1.16	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	53.12	6.30	2.25	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	77.50	8.40	1.49	0.81	0.41	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	98.08	12.32	2.05	0.51	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	50.81	8.47	1.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	47.31	4.66	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	81.50	5.60	1.02	0.00	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	53.63	6.94	0.27	0.80	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	64.05	7.56	0.57	0.76	0.76	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	87.74	13.50	1.23	0.61	0.00	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	68.50	12.23	0.82	0.00	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	68.30	6.87	2.50	0.42	0.62	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	77.07	5.61	1.40	0.56	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	80.37	5.15	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	66.19	10.45	0.87	0.87	1.16	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	73.54	7.77	0.30	0.90	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	53.67	6.09	0.00	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	68.22	9.19	1.41	1.77	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	78.18	5.90	0.74	0.00	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	55.26	6.91	1.15	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	77.52	8.44	0.38	0.77	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	88.32	9.06	0.57	3.40	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	54.15	4.92	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	85.86	9.49	0.45	0.00	0.00	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	84.74	10.77	2.87	2.15	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	59.01	8.22	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	83.61	6.32	0.74	1.86	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	67.63	10.77	0.86	0.86	2.15	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	63.37	7.71	0.86	0.86	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	75.96	9.66	2.00	1.00	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	105.58	7.24	0.00	0.60	1.21	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	64.70	11.38	2.84	0.00	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	79.06	8.59	2.06	1.72	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	101.45	10.20	2.15	3.22	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	76.09	6.73	2.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	88.16	8.15	1.11	2.59	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	69.78	8.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	92.02	6.35	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	84.03	12.40	0.80	2.00	0.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	108.30	8.00	1.45	0.73	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	82.02	6.90	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	78.92	11.84	1.48	1.97	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	77.16	8.47	1.88	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	72.91	11.56	1.51	1.01	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	76.16	9.46	0.45	2.25	0.90	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	72.29	6.88	1.72	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	61.90	8.46	0.89	0.89	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	78.99	7.43	0.78	1.17	0.39	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	81.81	5.28	2.64	0.66	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	59.16	6.75	1.04	0.00	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	74.39	7.00	1.31	1.75	0.88	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	87.78	9.50	0.56	0.56	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	59.18	7.07	0.44	0.88	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	69.43	7.71	0.77	1.16	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	66.84	5.06	0.00	1.52	1.52	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	65.36	8.17	1.92	0.00	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	82.29	7.16	0.80	0.80	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	75.35	6.08	0.61	1.82	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	74.01	4.15	0.69	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	67.26	7.98	2.28	0.38	1.90	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	69.72	7.23	0.52	1.03	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	58.05	3.02	1.21	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	66.87	9.82	1.27	1.27	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	72.50	7.46	1.07	0.53	1.07	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	59.19	5.75	2.30	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	63.25	8.23	0.51	2.57	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	82.76	12.03	1.41	2.12	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	68.67	5.11	0.57	1.13	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	69.06	9.98	2.08	0.83	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	79.87	3.92	1.57	3.13	2.35	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	73.07	3.76	1.25	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	75.27	7.43	1.86	2.32	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	83.63	7.36	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	81.80	6.42	0.00	1.60	1.07	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	74.76	7.68	2.42	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	92.69	6.42	0.92	0.92	1.84	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	83.58	7.11	0.89	0.89	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	74.65	7.98	0.00	1.71	0.57	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	91.26	9.97	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	79.34	3.28	0.00	1.64	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	75.73	9.35	4.01	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	89.16	10.66	1.56	0.26	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	86.87	5.97	0.00	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	93.54	12.47	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	366.03	21.65	10.48	0.91	0.91	0.46
Macrophage - monocyte derived, donor2	11313-117C8	239.48	21.84	7.52	1.47	1.28	0.55
Macrophage - monocyte derived, donor3	11389-118C3	264.78	24.12	9.57	2.23	0.92	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	175.24	5.31	13.28	0.53	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	183.80	12.52	11.09	0.63	0.95	0.79
Mallassez-derived cells, donor3	11930-125I4	156.92	8.62	9.17	1.11	0.42	1.81
Mammary Epithelial Cell, donor1	11273-116H4	45.24	6.08	1.49	0.10	0.20	0.10
Mammary Epithelial Cell, donor2	11350-117G9	51.83	6.08	2.03	0.29	0.58	0.87
Mammary Epithelial Cell, donor3	11422-118F9	111.74	14.22	1.75	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	38.64	2.03	0.00	0.00	0.00	2.03
Mast cell, donor1	11563-120D6	473.66	55.69	9.52	0.76	1.51	1.30
Mast cell, donor2	11565-120D8	546.21	103.42	10.40	1.19	1.78	2.08
Mast cell, donor3	11566-120D9	518.01	93.20	6.08	1.58	1.13	1.13
Mast cell, donor4	11567-120E1	545.52	91.30	6.38	1.42	1.77	1.77
Mast cell, expanded and stimulated, donor5	11940-126A5	323.59	57.66	4.88	1.11	1.44	2.00
Mast cell, expanded and stimulated, donor8	11942-126A7	229.97	28.02	2.33	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	528.30	76.29	8.26	4.36	3.67	1.95
Mast cell, expanded, donor8	11941-126A6	454.23	53.39	7.36	1.51	1.84	1.00
Melanocyte - dark, donor1	11502-119F8	169.94	16.02	5.47	0.90	0.20	1.29
Melanocyte - dark, donor2	11582-120F7	356.81	15.92	12.11	1.73	2.08	2.08
Melanocyte - dark, donor3	11663-122F7	862.55	28.03	52.45	1.38	2.17	4.27
Melanocyte - light, donor1	11274-116H5	1232.25	28.21	85.57	1.88	3.53	6.11
Melanocyte - light, donor2	11351-117H1	1348.55	32.76	96.91	1.36	8.87	6.14
Melanocyte - light, donor3	11423-118G1	661.69	25.15	46.83	4.34	1.73	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	445.14	23.12	16.66	3.54	3.02	3.23
Melanocyte, donor2 (MC+2)	12739-135I3	584.41	13.98	20.17	2.15	1.34	2.69
Melanocyte, donor3 (MC+3)	12837-137B2	778.65	16.34	38.30	5.09	5.09	5.89
Meningeal Cells, donor1	11493-119E8	215.00	19.11	12.16	0.25	0.62	0.87
Meningeal Cells, donor2	11573-120E7	205.55	20.25	10.56	0.44	0.44	0.88
Meningeal Cells, donor3	11654-122E7	128.61	17.28	5.38	0.65	0.49	0.98
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	118.62	19.39	3.99	0.29	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	218.77	12.08	11.47	0.20	0.50	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	893.63	44.68	22.34	1.31	3.94	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	396.37	31.40	15.70	0.00	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	159.31	14.35	7.89	2.15	1.44	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	249.67	16.94	15.04	0.64	1.48	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	270.93	17.09	11.06	1.01	1.51	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	118.23	17.36	3.96	0.00	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	83.29	16.80	3.65	2.19	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	127.06	18.82	2.66	0.20	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	146.82	13.16	3.19	0.14	0.69	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	146.46	14.87	4.83	0.37	0.37	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	101.44	8.42	4.87	0.00	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	90.51	5.64	3.86	0.59	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	121.45	7.01	0.00	0.00	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	146.01	20.49	5.76	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	179.70	14.89	5.32	0.35	1.77	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	77.24	10.32	4.07	0.31	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	76.20	7.98	2.18	2.18	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	282.94	16.97	18.30	0.80	1.86	0.53
Mesothelial Cells, donor2	12156-128G5	178.17	10.01	14.51	2.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	181.02	16.48	11.13	1.23	0.65	1.08
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	148.54	17.55	13.50	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	444.53	26.35	12.81	3.45	1.23	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	394.28	22.67	13.25	1.47	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	480.53	62.23	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	335.98	17.36	10.85	2.17	2.48	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	357.41	23.03	8.71	1.04	2.28	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	312.67	30.11	9.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	378.15	20.52	16.02	2.25	2.25	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	382.62	31.65	12.10	0.93	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	545.05	58.40	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	372.29	22.15	9.75	2.85	1.42	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	390.42	29.30	12.27	1.58	1.98	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	504.54	17.10	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	363.71	18.58	15.04	8.85	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	452.89	26.22	19.38	2.66	1.90	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	246.07	18.42	9.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	381.37	17.83	9.76	1.06	2.97	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	237.57	16.57	9.21	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	332.03	16.10	9.24	1.49	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	243.12	11.74	5.03	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	237.65	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	355.53	17.81	12.04	3.01	2.26	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	303.50	17.11	11.17	1.66	0.24	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	223.92	16.03	3.87	0.00	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	299.09	17.50	9.21	2.30	0.92	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	297.42	19.56	11.57	0.42	0.42	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	230.53	15.08	7.75	0.61	0.82	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	302.07	20.38	7.72	2.36	2.57	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	248.30	19.34	9.78	0.89	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	340.51	20.64	20.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	203.25	11.83	5.26	0.88	1.31	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	212.41	15.21	3.55	0.00	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	192.21	16.57	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	209.28	13.32	7.07	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	282.91	16.17	7.94	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	178.81	18.54	3.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	328.70	15.86	11.05	3.84	1.44	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	301.77	18.01	10.81	2.00	2.00	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	178.26	17.83	5.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	327.88	17.52	10.01	2.00	1.00	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	431.15	26.95	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	116.19	18.35	4.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	217.65	10.95	9.20	3.50	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	171.07	11.04	8.83	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	126.80	11.53	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	214.95	9.67	5.70	1.49	0.25	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	138.48	6.96	4.87	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	163.53	15.47	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	206.49	12.65	6.15	2.05	0.34	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	155.79	13.13	5.69	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	100.49	10.65	1.42	0.71	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	169.17	9.82	5.89	1.40	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	164.59	9.14	2.08	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	131.70	11.07	5.24	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	159.88	7.84	7.24	1.51	2.11	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	177.39	10.43	6.26	0.42	0.83	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	7.22	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	104.36	9.24	1.85	1.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	194.64	10.24	5.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	112.62	9.40	2.49	0.14	0.41	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	153.42	7.52	4.15	0.78	0.26	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	173.31	9.87	4.72	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	122.59	7.62	2.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	100.35	6.94	3.20	0.27	1.07	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	222.70	11.37	5.39	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	103.54	8.05	2.97	0.00	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	147.47	5.41	5.41	1.27	0.64	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	171.38	8.62	6.19	0.22	0.44	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	123.62	8.34	1.90	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	135.23	8.81	5.11	0.28	0.85	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	214.83	11.31	6.39	0.98	1.23	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	149.88	9.12	2.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	146.43	6.76	5.00	0.88	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	199.81	11.82	6.34	0.86	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	120.76	6.59	3.30	0.00	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	145.32	9.83	3.87	0.60	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	301.35	11.30	11.30	0.00	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	497.25	32.08	12.48	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	539.51	30.56	14.46	4.93	1.97	3.29
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	520.72	45.23	12.62	1.05	3.16	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	620.34	23.72	20.56	3.16	2.77	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	689.18	40.98	13.04	0.00	1.86	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	565.55	25.16	13.89	0.75	3.38	2.25
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	604.60	34.09	15.71	1.60	1.86	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	319.28	17.87	9.16	1.58	1.13	0.90
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	583.49	24.31	12.52	1.47	2.21	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	480.38	21.25	14.66	2.20	1.83	3.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	409.12	28.00	9.33	6.22	4.67	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	146.44	8.02	4.81	0.00	2.67	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	405.71	27.05	23.18	0.00	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	627.17	34.34	29.29	5.05	5.05	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	276.17	24.46	8.01	1.26	0.84	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	39.50	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	19.71	1.27	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	75.52	6.04	3.02	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	99.80	0.00	0.00	0.00	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	200.78	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	300.75	20.04	18.53	2.37	2.15	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	446.83	18.81	11.50	0.52	3.14	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	337.75	26.70	5.34	2.67	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	298.84	26.71	8.76	0.42	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	130.44	9.51	2.66	1.52	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	119.69	17.55	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	401.17	30.60	8.16	0.68	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	134.15	18.38	7.35	0.00	3.68	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	509.36	43.95	10.04	2.09	2.93	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	334.01	26.73	7.21	0.00	0.46	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	340.22	30.27	6.49	1.35	1.08	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	260.06	18.50	6.52	0.63	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	378.58	11.13	11.13	11.13	33.40	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	477.49	38.22	8.44	3.47	1.49	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	209.23	14.62	4.33	0.81	2.44	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	342.74	21.76	4.76	1.81	1.13	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	357.63	27.92	4.90	0.82	1.63	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	241.12	14.58	7.65	2.00	0.36	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	385.63	31.30	12.73	1.06	1.59	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	494.65	41.42	7.20	0.60	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	138.82	6.56	2.63	0.33	2.63	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	316.63	25.37	5.85	1.63	0.98	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	189.79	11.64	5.64	0.88	0.53	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	375.53	28.13	10.55	0.70	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	413.74	19.31	9.19	2.30	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	327.45	25.06	7.07	0.96	0.96	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	97.26	6.21	3.79	2.41	2.76	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	91.02	15.17	10.11	0.00	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	176.89	13.14	5.12	0.67	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	288.33	11.85	7.62	0.00	1.27	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	273.43	10.68	3.09	0.95	0.71	2.14
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	297.04	29.19	8.16	0.43	0.86	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	135.42	0.00	18.06	9.03	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	262.91	25.66	6.00	0.67	1.00	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	132.55	15.33	8.12	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	257.92	19.44	9.13	0.40	0.00	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	341.74	22.29	4.64	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	196.00	13.24	4.92	0.76	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	182.17	17.27	2.61	0.33	0.98	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	257.98	22.66	4.36	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	123.47	10.40	4.07	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	292.79	24.69	6.17	0.88	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	303.83	20.61	4.65	3.32	2.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	321.44	26.29	5.46	1.49	2.48	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	142.41	18.76	3.83	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	280.37	22.08	6.96	0.30	2.12	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	171.51	13.70	5.53	0.66	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	306.30	18.97	8.81	0.68	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	127.74	5.11	15.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	380.44	29.87	9.75	1.22	2.44	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	130.30	11.02	2.52	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	360.16	23.00	4.54	0.30	1.21	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	211.23	20.57	3.16	0.00	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	91.83	4.53	0.00	1.13	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	101.16	0.00	5.06	5.06	10.12	0.00
Myoblast, donor1	11241-116D8	295.04	9.81	20.25	1.99	1.49	1.99
Myoblast, donor2	11322-117D8	213.27	20.71	4.99	1.53	2.49	2.11
Myoblast, donor3	11398-118D3	191.03	15.13	10.43	0.34	0.84	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	13.57	11.09	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	11.69	8.61	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	15.68	7.84	0.00	0.00	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	10.49	8.10	0.18	0.55	0.00	0.00
Neural stem cells, donor1	11275-116H6	221.39	38.83	7.98	0.00	0.00	0.73
Neural stem cells, donor2	11352-117H2	82.80	25.03	7.70	0.00	0.00	0.00
Neurons, donor1	11494-119E9	48.93	18.21	5.69	0.00	3.41	0.00
Neurons, donor2	11574-120E8	87.62	37.65	9.25	0.66	0.88	0.44
Neurons, donor3	11655-122E8	50.15	20.55	4.11	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	7.42	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.11	1.22	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	142.96	19.12	1.90	0.59	1.42	1.78
Nucleus Pulposus Cell, donor2	11409-118E5	196.34	14.98	3.26	1.30	0.33	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	151.62	13.44	3.81	0.80	1.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	115.77	16.79	2.62	1.38	1.10	0.69
Olfactory epithelial cells, donor2	11934-125I8	131.43	16.36	3.04	2.03	2.61	3.18
Olfactory epithelial cells, donor3	11935-125I9	181.95	15.89	5.22	2.27	2.16	1.14
Olfactory epithelial cells, donor4	11936-126A1	179.70	22.11	3.31	0.78	1.27	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	211.24	19.26	7.82	0.00	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	254.17	20.42	9.15	0.85	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	441.24	16.00	13.72	2.29	5.72	5.72
Osteoblast - differentiated, donor3	11425-118G3	230.28	12.41	5.59	1.24	1.24	1.24
Osteoblast, donor1	11277-116H8	145.01	23.84	6.25	0.78	0.00	0.20
Osteoblast, donor2	11354-117H4	89.19	16.15	2.81	0.00	1.40	1.40
Osteoblast, donor3	11426-118G4	152.49	23.46	4.09	0.89	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	284.46	14.40	11.20	1.68	1.60	2.44
Pericytes, donor1	11491-119E6	317.67	24.59	19.47	0.45	0.67	1.11
Pericytes, donor2	11571-120E5	184.26	18.79	12.45	1.13	1.13	0.91
Pericytes, donor3	11652-122E5	213.62	22.38	9.16	0.61	0.61	1.02
Perineurial Cells, donor1	11499-119F5	89.85	13.45	4.41	0.11	0.57	0.79
Perineurial Cells, donor2	11579-120F4	363.53	14.45	18.77	1.01	0.92	1.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	18.49	10.20	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.41	4.16	0.00	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.59	4.92	0.26	0.00	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	98.54	8.13	4.07	0.00	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	141.94	16.63	4.44	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	73.03	12.76	2.16	0.39	0.20	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	216.14	12.34	7.28	4.43	3.80	4.43
Preadipocyte - breast, donor1	11467-119B9	338.03	13.32	15.94	0.56	0.94	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	216.81	13.31	10.44	1.31	0.39	0.65
Preadipocyte - breast, donor2	11328-117E5	307.55	17.34	12.38	4.05	2.48	1.13
Preadipocyte - omental, donor1	11468-119C1	327.99	13.11	17.05	1.49	1.39	1.07
Preadipocyte - omental, donor2	11329-117E6	292.44	11.35	17.02	0.87	0.87	0.87
Preadipocyte - omental, donor3	11403-118D8	177.06	12.61	8.17	0.29	0.57	0.86
Preadipocyte - perirenal, donor1	11469-119C2	205.71	11.81	5.91	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	249.38	21.50	12.90	0.00	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	148.21	15.23	5.49	1.24	0.53	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	207.92	15.84	9.03	1.02	1.02	1.53
Preadipocyte - visceral, donor1	11280-116I2	248.05	15.37	9.69	0.75	0.19	1.40
Preadipocyte - visceral, donor2	11357-117H7	403.12	22.09	11.50	6.90	3.22	1.38
Preadipocyte - visceral, donor3	11429-118G7	214.31	16.30	4.91	1.15	1.04	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	90.81	8.60	3.47	0.45	1.81	0.60
Prostate Epithelial Cells, donor2	11331-117E8	215.04	9.75	8.40	2.30	2.03	2.03
Prostate Epithelial Cells, donor3	11404-118D9	83.83	10.04	1.59	0.18	0.37	0.80
Prostate Stromal Cells, donor1	11254-116F3	180.53	9.11	8.09	1.03	1.14	1.59
Prostate Stromal Cells, donor2	11332-117E9	263.57	12.19	9.86	2.69	1.97	2.69
Prostate Stromal Cells, donor3	11405-118E1	330.55	21.69	16.06	2.71	1.56	1.98
Renal Cortical Epithelial Cells, donor1	11516-119H4	227.38	31.02	10.58	0.00	0.00	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	221.17	28.14	7.07	1.18	1.39	1.87
Renal Epithelial Cells, donor1	11517-119H5	277.96	43.62	15.72	0.51	0.00	2.03
Renal Epithelial Cells, donor2	11597-120H4	224.78	27.74	10.67	0.71	0.71	3.56
Renal Epithelial Cells, donor3	11678-122H4	221.47	27.21	5.08	0.85	1.06	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	448.00	36.09	19.06	3.40	0.68	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	549.03	26.55	26.01	2.43	2.02	2.96
Renal Glomerular Endothelial Cells, donor3	11675-122H1	147.64	12.88	4.22	0.89	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	285.48	25.95	9.98	2.00	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	207.76	28.39	7.26	0.44	0.44	0.66
Renal Mesangial Cells, donor2	11598-120H5	265.21	36.37	10.66	0.00	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	313.75	46.05	9.15	0.55	0.55	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	130.45	15.84	4.03	0.27	0.81	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	125.24	18.98	2.53	0.84	0.84	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	184.75	30.47	4.44	1.35	1.16	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	228.95	36.04	8.04	0.26	0.78	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	167.42	34.68	6.25	0.85	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	192.45	29.84	4.12	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	213.52	14.80	7.28	1.25	1.00	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	98.22	10.56	2.27	0.13	0.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	144.73	13.40	5.36	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	129.34	9.91	1.65	0.00	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	106.15	9.86	1.74	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	37.58	5.98	1.04	0.26	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.28	10.63	1.29	0.30	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	69.94	11.82	2.01	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	73.93	12.03	1.86	0.37	0.62	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	73.54	12.12	2.68	0.82	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	75.12	12.02	2.54	0.46	0.23	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.78	7.12	1.10	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	60.66	10.59	1.82	1.06	0.76	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	64.15	12.54	2.15	0.00	0.54	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	63.84	6.89	0.43	0.29	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	67.72	12.34	1.72	0.75	0.54	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	65.94	11.95	1.11	0.44	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	56.40	5.93	1.15	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.34	10.34	1.21	0.37	0.37	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	76.67	12.59	1.32	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	56.67	5.31	1.19	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	52.47	9.73	1.27	0.49	0.49	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	70.85	9.36	1.15	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	54.25	7.48	0.75	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.42	12.33	1.68	0.28	1.68	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	53.32	9.57	1.37	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	56.34	7.29	1.64	0.18	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.31	12.75	1.96	0.37	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	68.50	10.34	0.81	0.13	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	72.41	7.55	0.24	0.24	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	73.81	11.71	0.79	1.59	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	69.22	10.29	0.70	0.23	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	59.93	7.46	1.04	0.21	0.00	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	72.78	11.50	1.55	1.33	0.66	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	62.04	11.70	1.04	0.42	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	66.62	7.94	1.08	0.27	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	49.04	9.37	1.02	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	54.56	10.22	0.96	0.39	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	66.37	4.81	1.72	0.34	0.52	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	52.81	9.60	1.10	0.41	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	59.43	9.36	1.64	0.33	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	66.47	6.99	1.19	0.34	0.34	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	70.58	11.69	1.33	0.15	0.30	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	62.91	7.73	2.13	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	90.01	8.02	2.49	0.14	0.69	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	74.05	14.05	1.67	0.24	0.95	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	81.02	11.08	2.42	0.00	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	100.48	9.13	1.98	0.09	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	175.03	14.67	4.89	0.70	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	128.14	10.28	3.93	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	112.35	10.77	1.47	0.49	0.37	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	121.39	8.44	2.18	0.00	0.87	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	145.41	18.86	5.48	1.22	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	110.31	8.74	1.81	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	198.59	18.32	5.43	1.13	0.90	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	190.81	18.27	2.70	0.00	0.30	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	128.58	5.79	4.01	0.47	0.94	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	185.70	11.95	5.34	2.56	2.13	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	193.51	15.63	1.80	1.80	0.60	1.80
Schwann Cells, donor1	11498-119F4	186.75	23.89	4.51	0.94	0.75	1.32
Schwann Cells, donor2	11578-120F3	119.08	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	210.54	19.72	7.01	2.63	1.53	1.75
Sebocyte, donor1	11220-116B5	234.99	20.82	9.31	0.00	0.55	1.10
Sebocyte, donor2	11301-117B5	139.25	8.73	5.06	0.92	0.46	0.46
Sebocyte, donor3	11378-118B1	160.56	17.31	5.57	1.44	0.41	0.21
Sertoli Cells, donor1	11255-116F4	188.85	16.57	21.54	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	497.09	14.12	14.12	5.65	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	238.86	19.09	10.82	0.09	0.35	0.88
Skeletal Muscle Cells, donor2	11358-117H8	410.58	24.58	30.36	3.61	3.61	0.72
Skeletal Muscle Cells, donor3	11430-118G8	230.75	41.80	10.03	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	154.42	15.55	2.67	0.94	0.79	1.26
Skeletal Muscle Cells, donor5	11455-119A6	144.93	14.12	2.08	1.49	0.45	0.74
Skeletal Muscle Cells, donor6	11459-119B1	106.81	14.31	3.85	0.46	0.31	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	217.99	20.79	5.29	0.50	1.51	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	223.31	21.26	3.00	2.14	2.14	2.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	211.71	21.63	7.04	1.09	0.50	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	166.99	13.65	15.25	0.34	0.34	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	178.77	29.67	13.75	3.62	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	315.24	26.56	8.81	2.48	1.38	0.96
Skin - palm, donor1	10286-104F7	104.76	21.49	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	136.08	12.54	3.89	0.58	0.86	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.88	7.36	3.27	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	126.84	11.55	1.43	1.69	1.04	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	156.11	8.06	7.23	0.70	0.42	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	134.19	10.55	4.08	0.28	1.27	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	56.03	5.50	3.81	0.21	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	147.35	11.02	4.05	0.60	0.45	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	351.79	13.58	11.11	1.85	2.16	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	198.54	9.56	12.67	0.44	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	297.44	25.28	19.99	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	123.98	9.50	26.96	0.00	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	253.20	18.51	14.18	0.00	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	363.11	21.63	17.77	0.77	0.77	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	89.07	13.01	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	219.58	23.82	11.31	0.00	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	99.08	11.30	3.55	1.11	0.89	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	134.69	12.93	4.61	1.02	1.02	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	234.75	18.23	13.02	0.65	0.65	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	225.33	19.20	14.47	1.18	0.89	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	212.12	13.95	11.53	1.00	1.85	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	303.06	27.17	11.22	1.14	0.65	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	136.39	7.31	4.87	0.30	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	296.51	29.30	6.57	0.00	0.25	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	18.36	18.36	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	212.67	22.89	6.20	1.43	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	212.95	15.04	10.18	0.44	0.44	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	190.49	12.70	7.32	2.15	2.37	1.72
Smooth Muscle Cells - Colonic, donor3	11396-118D1	180.42	12.28	8.08	0.94	1.57	1.68
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	255.37	21.81	14.69	0.00	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	289.95	20.48	9.70	0.00	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	268.67	26.60	14.35	0.60	0.90	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	202.79	21.85	12.29	0.00	0.68	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	200.25	12.01	7.77	0.47	1.10	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	240.43	18.32	7.25	0.50	1.21	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	147.91	9.33	5.23	0.68	1.37	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	253.00	16.91	9.66	1.21	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	107.56	14.04	6.09	0.00	0.26	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	122.51	10.92	3.86	0.27	0.53	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	321.69	14.78	16.53	3.38	1.63	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	425.39	22.58	18.01	1.78	2.03	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	313.01	22.47	10.40	0.45	0.75	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	355.58	40.51	8.25	2.25	6.75	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	518.18	28.43	342.44	3.88	16.80	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	241.84	26.04	6.51	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	281.72	28.27	10.60	1.01	2.02	3.53
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	259.18	12.85	10.03	1.57	1.88	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	340.13	23.01	14.16	2.65	1.18	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	128.29	12.50	3.33	0.17	0.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	314.87	17.75	7.01	2.34	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	192.42	18.28	13.24	0.14	0.58	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	114.22	17.85	4.59	1.53	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	123.54	15.23	4.14	0.94	0.38	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	136.39	17.75	5.31	0.28	0.42	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	184.42	16.67	8.13	0.42	0.50	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	375.71	37.14	6.19	0.00	1.90	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	167.84	23.98	9.79	0.73	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	134.78	11.27	5.52	0.22	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	186.37	19.31	7.90	2.34	2.05	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	370.06	8.94	9.33	1.17	0.58	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	362.04	10.84	14.28	2.38	1.06	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	310.58	10.41	18.23	2.98	2.98	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	482.23	11.14	20.84	2.87	2.16	3.23
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	467.87	13.06	21.01	2.27	0.57	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	183.54	14.97	3.94	1.97	1.18	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	224.24	6.09	7.11	1.02	1.78	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	300.29	15.97	8.79	2.00	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	471.09	14.21	10.87	3.76	2.51	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	533.99	22.92	12.38	0.92	1.83	2.29
Synoviocyte, donor1	11291-117A4	108.74	14.64	4.21	0.00	0.50	0.67
Synoviocyte, donor2	11368-117I9	297.20	14.42	6.37	1.84	2.01	1.68
Synoviocyte, donor3	11440-118H9	273.90	11.84	4.02	1.79	2.23	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	281.93	26.44	10.01	0.36	2.50	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	291.36	19.82	3.96	1.98	0.00	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	225.99	24.78	9.72	0.46	1.62	2.55
Tracheal Epithelial Cells, donor1	11292-117A5	81.86	7.74	1.94	0.14	0.07	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	106.69	13.53	3.48	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	129.99	11.45	2.29	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	99.90	9.60	1.97	0.25	0.62	0.49
Urethra, donor2	10319-105A4	131.29	21.58	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	150.10	13.81	6.91	0.80	0.80	0.27
Urothelial Cells, donor2	11600-120H7	102.54	11.22	6.01	0.80	0.40	2.00
Urothelial Cells, donor3	11681-122H7	135.69	11.92	2.98	0.46	0.69	0.92
Urothelial cells, donor0	11216-116B1	151.79	14.71	3.79	0.45	0.67	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	20.47	8.90	0.00	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	7.15	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	16.43	1.37	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	11.71	5.85	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.94	2.91	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	16.66	1.04	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	16.52	1.84	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	23.74	6.39	0.00	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	138.53	13.32	6.04	0.37	0.12	0.12
Wilms' tumor cell line:HFWT	10597-108E3	51.04	13.20	2.64	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	112.84	25.98	1.40	0.00	0.28	0.28
achilles tendon, donor2	10292-104G4	90.93	14.47	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.71	10.71	0.00	0.25	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	14.86	10.22	0.46	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	57.45	32.76	0.83	0.24	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	177.96	37.01	4.08	0.82	1.09	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	99.78	23.05	0.84	1.97	0.28	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	77.40	17.55	1.69	0.42	0.63	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	22.05	4.63	0.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	67.42	8.81	0.00	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	253.18	32.26	3.68	2.04	1.63	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	42.71	13.98	0.39	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	184.37	13.43	4.23	1.29	0.74	2.21
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	109.21	23.40	3.90	0.00	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	39.27	10.22	0.00	0.70	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	34.95	11.65	0.00	0.26	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	37.99	12.27	0.00	1.17	0.88	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	51.59	10.22	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	212.62	13.16	6.17	0.82	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	79.19	17.19	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	45.66	8.11	0.85	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	47.92	9.71	1.21	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	42.85	6.26	0.48	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	154.14	18.26	4.01	1.56	0.67	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	58.70	8.01	0.67	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	14.87	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	30.89	4.52	1.13	0.00	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	22.68	6.11	0.00	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	88.10	41.24	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	46.63	16.48	0.24	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	300.16	16.29	6.05	0.78	1.24	0.93
adipose, donor1	10184-103D4	89.72	6.45	4.10	1.17	0.59	0.59
adipose, donor2	10185-103D5	480.54	106.25	8.92	0.41	1.22	0.41
adipose, donor3	10186-103D6	239.07	42.75	6.81	0.82	0.54	1.09
adipose, donor4	10187-103D7	133.48	15.60	8.67	1.73	1.73	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	57.76	32.35	0.79	0.16	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	560.20	32.74	3.64	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	16.01	7.74	0.00	0.00	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	73.25	22.51	0.36	0.36	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	67.93	12.98	2.32	0.23	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	39.22	7.78	0.68	0.34	0.68	0.34
amniotic membrane cells, donor3	12237-129G5	61.57	6.48	0.88	0.00	0.29	0.29
amygdala - adult, donor10196	10167-103B5	23.72	4.74	1.19	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	41.57	14.40	3.24	0.20	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	30.66	7.42	0.97	0.00	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	114.34	16.43	1.40	0.25	0.00	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.81	2.87	0.00	0.00	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.08	15.03	0.33	0.00	0.00	0.33
aorta, adult, pool1	10052-101G7	131.02	28.44	1.18	0.59	0.39	0.59
appendix, adult	10189-103D9	81.12	16.30	2.72	0.00	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.43	16.16	1.38	0.00	0.00	0.00
artery, adult	10190-103E1	89.67	9.51	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	134.00	29.41	5.65	0.58	0.43	1.01
b cell line:RPMI1788	10427-106D4	3.42	4.46	0.00	0.15	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	202.81	14.43	8.88	0.55	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	36.62	8.73	0.89	0.00	0.30	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	16.07	0.67	0.00	0.00	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	95.63	4.47	0.00	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	138.63	26.73	2.28	0.98	0.65	0.65
blood, adult, pool1	10053-101G8	6.64	6.64	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	29.12	4.28	1.71	0.00	0.86	0.00
bone marrow, adult	10192-103E3	132.94	10.12	2.02	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	46.13	16.40	4.10	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	34.41	11.36	2.67	0.22	0.22	0.22
brain, fetal, pool1	10085-102B4	106.86	45.41	8.01	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	48.56	6.94	0.66	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	19.35	3.00	0.37	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	378.18	23.36	3.16	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.73	8.38	0.13	0.00	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	85.04	19.17	0.93	0.62	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	97.38	41.90	3.91	1.61	1.15	2.99
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.43	6.05	0.48	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	55.95	19.75	2.35	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	7.33	2.30	0.11	0.00	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	15.84	5.07	0.32	0.00	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	60.42	16.50	2.40	0.27	0.80	0.27
caudate nucleus - adult, donor10196	10177-103C6	58.72	12.66	3.45	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	63.75	14.89	2.68	0.17	0.50	0.00
caudate nucleus, adult, donor10258	10379-105H1	87.11	14.52	10.70	0.00	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	102.55	11.72	4.76	0.37	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	17.48	8.74	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	22.21	21.78	1.28	0.43	0.00	0.00
cerebellum, adult, pool1	10083-102B2	12.07	10.00	1.72	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	34.04	14.11	2.49	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	40.34	9.58	0.76	0.00	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	32.89	2.92	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	49.89	7.76	1.29	0.00	0.14	0.29
cervical cancer cell line:ME-180	10553-107I4	18.89	3.81	0.50	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	168.72	26.88	4.30	0.31	0.63	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	239.10	17.97	11.98	0.42	0.42	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	121.17	20.26	4.97	0.12	0.50	0.25
choriocarcinoma cell line:SCH	10785-110H2	254.56	17.37	5.79	0.86	1.36	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	175.27	17.08	4.27	0.47	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	94.88	15.96	5.41	1.42	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	143.48	15.41	4.77	0.99	0.99	0.40
chorionic membrane cells, donor3	12240-129G8	128.58	19.78	3.30	1.10	1.10	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	233.26	19.19	7.07	3.03	4.04	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	84.14	14.41	2.50	0.38	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	119.74	28.09	0.42	0.21	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	66.51	14.64	0.51	0.00	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	58.53	14.51	0.97	0.24	0.73	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	41.94	10.59	0.41	0.20	0.20	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	49.47	15.90	1.18	0.00	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	64.11	16.94	0.26	0.00	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	270.18	119.55	3.43	5.94	5.26	3.43
clear cell carcinoma cell line:TEN	10636-108I6	32.27	7.98	0.52	0.52	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	147.17	18.49	6.59	0.37	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	69.17	28.51	1.14	0.38	1.52	2.28
colon, adult, donor1	10082-102B1	94.01	16.66	3.57	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	105.28	13.75	2.00	0.00	0.24	0.12
colon, fetal, donor1	10070-101I7	151.41	20.39	0.62	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	87.09	18.33	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	5.95	2.12	0.42	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	7.24	2.87	0.30	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	7.90	3.81	0.14	0.00	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	85.58	27.53	4.31	0.00	0.11	0.11
cruciate ligament, donor2	10295-104G7	129.68	8.92	1.62	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	96.31	7.22	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	37.68	11.04	1.68	0.96	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	8.50	11.71	0.00	0.00	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	38.98	5.13	1.54	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	102.07	8.67	2.89	0.00	0.48	0.72
ductus deferens, adult	10196-103E7	57.31	13.46	0.00	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	122.42	14.40	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	78.71	11.77	4.41	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	73.59	9.91	2.64	0.17	0.33	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	77.50	5.55	5.11	0.22	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	70.64	10.89	2.15	0.43	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	134.42	27.13	0.62	0.62	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	257.61	46.92	5.15	1.21	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	141.41	23.77	2.16	0.31	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	152.36	15.76	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	64.69	10.73	1.34	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	94.97	21.20	2.36	0.36	0.18	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	123.18	16.56	3.70	1.13	1.13	0.16
epidermoid carcinoma cell line:A431	10426-106D3	55.25	8.34	0.44	0.22	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	155.74	23.10	4.29	0.33	0.77	0.66
epididymis, adult	10197-103E8	134.80	23.44	1.88	0.63	0.42	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	112.12	24.13	2.84	0.35	0.35	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.07	4.72	1.18	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	66.44	12.97	1.57	0.79	0.92	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	58.86	13.98	1.57	0.00	0.79	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	66.99	15.46	0.90	0.34	0.45	1.01
esophagus, adult, pool1	10015-101C6	141.64	13.17	4.78	0.11	1.06	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	105.70	26.17	9.39	0.00	0.63	0.88
eye - muscle inferior rectus, donor1	10272-104E2	72.44	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	67.33	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	56.55	5.95	0.00	1.49	1.49	1.49
eye - muscle superior, donor2	10297-104G9	66.50	6.88	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	32.06	10.20	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	107.54	21.61	1.02	0.51	0.76	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	18.85	6.41	0.13	0.00	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	79.06	12.58	1.19	0.47	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	29.93	8.16	3.19	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	42.94	8.11	1.80	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	104.15	17.28	2.01	0.37	0.27	0.37
gall bladder, adult	10198-103E9	119.51	16.42	2.66	0.24	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	9.66	9.66	0.00	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	10.83	6.35	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	200.02	9.50	7.39	1.90	0.84	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	46.23	9.86	1.35	0.00	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	168.55	39.84	10.82	0.33	0.98	0.82
gastric cancer cell line:GSS	10560-108A2	128.13	72.30	3.66	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	111.94	15.08	6.17	1.83	1.60	0.91
giant cell carcinoma cell line:LU65	10487-107B1	44.06	7.46	0.80	0.23	0.23	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	341.50	36.11	9.10	0.28	0.84	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	73.83	13.47	1.75	0.25	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	133.21	19.00	6.65	0.53	0.21	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	113.90	17.70	4.07	0.42	0.56	0.56
glioblastoma cell line:T98G	10485-107A8	39.40	9.27	0.88	0.55	0.11	0.33
glioma cell line:GI-1	10413-106B8	323.34	33.68	11.72	0.88	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	55.40	13.12	0.73	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	73.72	17.33	0.98	0.00	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	79.41	16.43	5.48	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	107.12	7.99	5.86	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	92.99	12.24	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	73.17	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	133.76	17.28	4.16	0.64	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	171.71	12.86	10.56	2.30	1.38	0.46
hIPS +CCl2, biol_rep2	14384-156C1	207.60	13.26	9.15	0.46	1.37	0.46
hIPS +CCl2, biol_rep3	14385-156C2	186.79	10.95	10.31	0.00	0.64	1.29
hIPS, biol_rep1	14380-156B6	192.60	5.75	11.50	1.44	1.44	1.44
hIPS, biol_rep2	14381-156B7	129.63	7.54	15.77	1.37	0.00	1.37
hIPS, biol_rep3	14382-156B8	57.38	6.62	3.31	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.01	16.67	0.00	0.29	0.00	0.29
heart - mitral valve, adult	10205-103F7	111.81	11.36	1.79	0.60	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	66.94	11.50	0.26	0.00	0.26	0.78
heart - tricuspid valve, adult	10207-103F9	59.12	6.66	0.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	85.09	16.53	1.84	0.20	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	91.98	15.33	2.13	0.43	0.85	0.43
heart, adult, pool1	10016-101C7	64.39	11.27	1.61	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	98.37	23.21	2.36	0.21	0.41	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	90.09	19.13	1.54	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	40.43	2.38	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	164.86	18.67	4.75	1.10	1.10	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	176.36	23.43	4.61	0.73	1.58	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	202.01	20.61	5.76	0.61	0.71	1.52
hepatoma cell line:Li-7	10484-107A7	71.85	5.78	4.23	0.22	0.22	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.20	0.10	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	17.98	4.73	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	52.25	16.94	3.47	0.61	0.61	0.41
hippocampus, adult, donor10258	10374-105G5	14.94	2.99	1.99	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	40.18	13.04	3.52	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	164.79	18.92	14.04	1.83	4.27	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	267.63	29.06	14.73	3.73	1.77	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	253.64	24.37	8.63	2.29	2.03	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	337.19	53.00	9.02	1.13	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	366.14	68.43	5.68	2.07	3.61	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	307.10	52.77	4.56	0.76	1.14	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	235.61	37.66	4.09	0.29	2.04	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	298.80	47.39	4.31	1.29	1.72	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	247.32	29.20	5.00	0.00	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	111.77	23.21	6.39	0.00	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	198.49	39.21	5.63	1.29	0.64	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	119.85	22.89	3.37	0.67	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	212.19	31.45	12.83	2.66	2.66	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	195.54	20.14	9.83	3.93	3.93	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	153.60	14.84	8.73	6.11	2.62	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	320.73	47.15	8.78	0.76	1.34	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	312.66	44.92	9.59	0.87	0.87	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	224.89	18.49	7.00	2.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	409.00	68.01	5.84	2.07	2.45	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	430.16	74.12	12.73	2.27	3.18	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	374.00	62.02	5.64	1.88	0.31	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	214.91	41.48	11.27	0.82	1.47	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	187.83	33.68	8.13	1.16	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	232.86	41.55	9.86	1.49	1.20	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	305.20	31.59	16.63	2.40	2.96	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	293.84	31.67	15.98	2.28	1.71	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	207.83	21.64	13.88	4.08	2.86	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	233.43	23.59	8.45	3.17	2.82	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	265.75	29.46	6.65	0.63	0.95	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	249.06	38.43	6.05	1.21	0.61	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	246.67	37.23	4.65	1.03	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	290.90	37.86	4.65	0.00	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	188.29	28.73	6.93	1.03	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	178.44	25.82	9.46	3.07	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	259.73	31.80	13.63	2.27	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	202.98	34.28	8.40	1.01	1.34	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	275.32	34.05	14.97	1.93	1.93	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	221.49	25.40	12.48	1.78	3.57	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	294.15	32.20	14.63	2.44	0.98	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	236.55	32.09	3.97	1.53	1.53	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	94.34	9.76	3.25	3.25	3.25	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	169.44	25.81	4.30	0.66	2.32	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	236.43	35.57	4.93	1.64	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	189.63	30.04	2.53	0.72	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	177.58	31.32	3.56	1.78	1.07	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	175.43	22.67	9.55	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	141.52	29.79	7.99	0.95	1.08	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	154.09	29.90	4.85	0.00	1.08	1.08
immature langerhans cells, donor1	11904-125F5	0.24	0.24	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	13.47	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	32.93	13.15	4.26	0.19	0.00	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	38.69	11.71	0.65	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	102.93	13.32	5.11	0.20	0.50	0.40
kidney, fetal, pool1	10045-101F9	101.79	21.36	3.18	0.14	0.64	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	108.08	16.19	3.27	0.00	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	107.14	15.76	2.76	0.97	0.83	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	52.85	10.09	0.37	0.37	0.37	0.00
left atrium, adult, donor1	10079-102A7	145.48	17.98	5.99	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	107.20	11.12	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	63.20	13.13	1.09	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	463.79	28.02	22.27	5.39	7.18	3.95
leiomyoma cell line:15242A	10570-108B3	209.24	15.76	14.67	1.63	1.09	1.09
leiomyoma cell line:15425	10571-108B4	325.37	26.22	11.41	3.40	5.58	2.67
leiomyosarcoma cell line:Hs 5.T	10722-110A2	209.53	6.35	19.05	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	277.07	25.09	7.32	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	81.46	8.26	1.65	0.12	0.12	0.35
liposarcoma cell line:KMLS-1	10782-110G8	130.90	15.46	2.97	0.16	0.00	0.47
liposarcoma cell line:SW 872	10726-110A6	140.36	22.54	5.24	0.61	0.24	0.37
liver, adult, pool1	10018-101C9	60.12	9.24	1.30	0.00	0.32	0.16
liver, fetal, pool1	10086-102B5	67.73	13.17	4.70	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	54.83	11.37	1.31	0.00	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	92.64	15.50	4.80	0.37	0.74	0.92
locus coeruleus, adult, donor10258	10375-105G6	208.22	23.70	12.70	2.54	2.54	1.97
locus coeruleus, newborn, donor10223	10362-105F2	62.25	5.89	2.94	0.42	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	52.59	14.39	2.49	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	48.26	14.48	1.38	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	61.69	23.33	3.16	0.13	0.13	0.40
lung, adult, pool1	10019-101D1	169.51	18.66	3.78	0.35	0.83	0.24
lung, fetal, donor1	10068-101I5	142.13	11.42	2.85	0.00	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	334.50	26.12	3.21	0.46	0.46	0.46
lymph node, adult, donor1	10077-102A5	44.97	13.25	1.42	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	10.96	9.42	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.58	6.79	0.15	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	66.26	5.10	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	129.64	10.66	4.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	131.78	11.41	5.81	0.62	0.42	0.21
mature adipocyte, donor3	12233-129G1	98.38	9.01	2.84	0.47	0.71	0.00
mature adipocyte, donor4	12234-129G2	102.92	8.95	2.11	0.79	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.02	11.44	2.14	0.24	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	27.07	6.77	3.38	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	28.14	9.93	0.92	0.55	0.00	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	19.06	6.35	1.59	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	21.32	2.99	4.26	0.43	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	26.66	9.11	1.18	0.34	0.34	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	37.99	10.19	2.12	0.21	0.42	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	5.78	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	40.56	7.90	5.74	0.00	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	47.38	16.22	1.95	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	94.43	20.90	2.63	0.31	0.77	0.15
medulla oblongata, adult, pool1	10038-101F2	100.97	20.00	6.86	0.16	0.41	0.24
medulla oblongata, newborn, donor10223	10361-105F1	83.67	8.68	2.43	0.00	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	38.75	23.03	0.22	0.44	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	22.50	8.56	0.73	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	522.52	24.15	49.88	1.72	1.15	2.59
melanoma cell line:G-361	10465-106H6	252.19	17.65	7.06	0.81	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	246.93	17.01	7.24	4.16	1.99	2.71
merkel cell carcinoma cell line:MKL-1	10843-111E6	34.37	13.22	0.00	0.00	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	84.51	38.11	11.41	1.56	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	269.28	13.96	10.28	1.38	0.77	2.45
mesenchymal precursor cell - adipose, donor2	11748-123G2	373.38	11.82	12.18	1.09	2.36	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	364.41	12.42	18.63	2.90	2.07	2.90
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	309.89	14.19	9.13	1.40	2.39	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	356.64	18.10	13.86	1.16	1.73	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	323.44	15.27	8.33	1.39	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	471.82	10.47	22.66	3.60	3.09	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	489.16	13.23	18.06	3.34	3.57	3.45
mesenchymal precursor cell - cardiac, donor3	11754-123G8	237.69	10.21	7.03	1.59	0.93	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	217.55	14.18	9.18	0.81	1.49	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	245.12	11.67	11.24	0.85	1.14	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	221.00	12.84	9.22	0.99	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	149.03	12.59	6.37	0.42	1.25	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	262.51	18.15	6.63	3.49	1.75	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	197.43	13.27	4.49	0.82	0.82	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	217.11	15.82	7.55	1.44	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	227.28	17.79	8.79	0.93	1.45	2.48
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	221.84	13.00	11.86	1.37	1.82	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	259.71	9.65	15.94	0.84	1.68	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	223.11	13.90	8.22	1.94	1.05	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	245.17	16.63	11.47	2.10	1.84	1.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	262.13	29.08	8.10	1.47	2.58	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	191.15	13.16	10.59	2.00	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	122.09	18.52	5.47	2.53	2.95	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	416.48	15.53	13.70	3.65	1.37	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	378.82	15.09	11.51	3.07	2.05	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	423.00	17.01	13.61	1.83	1.05	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	444.57	20.95	11.71	3.39	2.16	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	383.39	14.36	13.65	3.06	3.06	3.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	435.93	16.58	9.82	2.71	2.03	2.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	458.99	16.90	13.36	1.96	0.79	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	433.73	13.44	12.97	4.63	0.93	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	917.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	481.66	16.73	15.29	2.88	3.17	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	448.43	20.75	11.82	1.56	1.56	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	436.72	18.27	14.66	3.85	2.88	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	301.40	20.53	8.07	1.47	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	433.00	14.43	13.09	0.67	4.70	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	450.73	17.60	18.01	2.05	2.46	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	442.44	18.04	14.60	1.29	2.58	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	530.48	32.81	5.47	16.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	470.01	30.99	10.33	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	417.03	17.86	17.21	3.25	3.57	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	478.69	24.73	17.46	2.91	1.45	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	621.57	20.79	19.72	2.13	2.67	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	468.58	18.81	9.00	4.91	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	535.27	22.55	13.22	3.11	3.50	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	447.03	23.09	16.79	6.30	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	552.37	27.82	12.92	4.97	3.97	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	543.46	23.84	28.60	0.00	9.53	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	506.39	24.31	10.67	1.78	2.37	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	492.26	18.28	8.53	4.87	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	405.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	563.08	21.54	14.57	1.27	3.80	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	432.16	14.83	7.59	3.45	2.41	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	406.20	10.75	12.90	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	375.23	3.99	11.98	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	241.07	10.33	0.00	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	198.44	8.15	4.07	0.81	0.41	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	209.73	7.15	7.15	0.79	1.59	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	183.93	4.13	2.95	0.00	1.77	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	195.13	6.23	1.87	1.56	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	199.16	12.03	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	201.05	10.64	1.18	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	146.38	5.14	0.00	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	189.31	11.01	4.82	2.07	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	152.90	14.84	3.96	1.48	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	124.49	13.46	3.36	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	135.48	5.09	5.72	1.91	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	259.52	18.94	5.24	0.00	2.01	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	255.13	21.81	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	281.29	22.81	6.34	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	545.59	13.96	22.45	2.43	1.82	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	542.28	31.63	27.11	9.04	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	526.33	19.77	22.24	3.29	2.47	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	225.21	9.13	7.54	0.79	0.60	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	244.34	12.66	5.19	1.62	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	257.71	11.20	7.13	3.06	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	25.53	5.42	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	267.19	33.07	9.92	0.71	0.94	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	46.10	7.65	2.32	0.23	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	183.76	8.55	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	101.11	6.06	3.80	0.41	0.51	1.23
mesothelioma cell line:Mero-25	10850-111F4	232.17	5.67	14.30	1.13	1.82	2.04
mesothelioma cell line:Mero-41	10851-111F5	128.84	19.80	5.38	0.00	0.73	0.73
mesothelioma cell line:Mero-48a	10852-111F6	105.84	19.93	3.99	0.66	0.89	0.89
mesothelioma cell line:Mero-82	10853-111F7	68.33	11.04	3.15	0.26	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	191.16	21.45	9.02	0.51	0.51	1.53
mesothelioma cell line:Mero-84	10855-111F9	131.44	16.68	5.31	0.25	0.51	1.01
mesothelioma cell line:Mero-95	10856-111G1	139.55	22.36	6.21	0.62	0.62	2.28
mesothelioma cell line:NCI-H2052	10847-111F1	109.33	20.37	3.64	0.50	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	99.55	5.07	4.34	0.90	0.54	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	429.79	36.21	18.45	2.22	2.73	3.42
mesothelioma cell line:NCI-H28	10845-111E8	215.79	28.25	8.65	2.54	1.02	1.53
mesothelioma cell line:No36	10857-111G2	271.40	22.51	10.76	0.98	2.61	2.28
mesothelioma cell line:ONE58	10858-111G3	330.29	21.68	10.57	2.98	2.44	4.88
migratory langerhans cells, donor1	11901-125F2	19.19	7.48	0.38	0.19	0.58	0.77
migratory langerhans cells, donor2	11902-125F3	19.29	8.67	0.12	0.24	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	47.56	14.36	0.90	0.00	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	162.59	15.67	3.26	2.94	2.61	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	112.11	17.59	2.76	1.48	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	52.52	9.91	0.92	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	3.81	2.47	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	118.27	9.42	3.33	0.74	0.74	0.37
myeloma cell line:PCM6	10474-106I6	6.72	3.76	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	107.04	22.83	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	174.96	11.57	3.92	0.00	0.59	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	78.55	6.69	1.34	0.11	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	64.57	6.10	0.59	0.44	0.22	0.22
nasal epithelial cells, donor2	12227-129F4	85.01	6.07	0.00	1.10	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	33.36	23.24	3.91	0.00	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	107.57	46.96	4.86	0.56	0.94	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	52.30	8.44	5.48	0.00	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	66.71	32.80	2.05	0.00	0.00	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	60.26	9.96	1.19	0.71	0.24	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	60.34	11.56	1.58	0.16	0.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	30.19	8.86	0.40	0.20	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.72	6.99	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	216.66	20.23	6.65	1.06	0.27	0.27
neutrophil PMN, donor1	12133-128D9	89.25	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	113.65	28.41	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	115.85	44.14	2.88	0.51	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	98.46	45.63	5.60	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	157.42	20.52	5.13	1.28	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	198.39	9.99	6.04	3.94	1.58	0.79
nucleus accumbens, adult, pool1	10037-101F1	48.56	13.69	3.94	0.00	0.09	0.00
occipital cortex - adult, donor10196	10172-103C1	30.91	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	37.57	9.12	1.07	0.00	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	36.39	10.19	4.00	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	65.60	19.16	2.36	0.26	0.79	0.26
occipital lobe, fetal, donor1	10073-102A1	103.41	81.10	21.03	0.43	2.15	0.43
occipital pole, adult, pool1	10036-101E9	28.23	9.38	2.60	0.00	0.16	0.16
olfactory region, adult	10195-103E6	31.52	8.41	2.29	0.38	0.00	0.19
optic nerve, donor1	10277-104E7	114.06	32.02	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	92.49	10.82	2.39	0.34	0.23	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	72.40	16.90	0.55	0.41	0.14	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	64.68	8.64	0.34	0.68	1.02	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	67.92	14.09	2.31	0.58	0.46	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	61.15	16.46	1.18	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	16.82	11.21	1.87	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	100.30	8.48	5.09	0.00	0.42	0.00
ovary, adult, pool1	10020-101D2	243.89	31.53	5.68	0.96	0.96	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	63.06	14.67	0.55	0.18	0.18	0.55
pancreas, adult, donor1	10049-101G4	62.08	29.16	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	180.02	16.21	3.63	0.28	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	199.99	16.18	7.33	3.07	1.19	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	123.52	20.20	3.15	0.50	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	32.49	10.34	2.75	0.09	0.18	0.18
parietal cortex, adult, donor10258	10373-105G4	22.02	10.28	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	26.33	10.35	3.76	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	31.35	7.13	0.86	0.29	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	34.01	12.34	2.56	0.35	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	125.11	42.67	13.58	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	37.01	8.22	5.98	0.37	0.00	0.37
parotid gland, adult	10199-103F1	78.93	34.53	0.62	1.85	0.62	0.62
penis, adult	10200-103F2	129.44	22.56	2.69	1.61	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	52.62	9.30	0.19	0.37	0.56	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.83	4.08	0.29	0.15	0.00	0.29
pineal gland - adult, donor10196	10179-103C8	20.64	3.87	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	20.73	7.70	0.00	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	22.57	5.64	0.00	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	125.46	39.46	4.05	0.00	2.02	5.06
pituitary gland, adult, donor10252	10162-103A9	132.38	19.80	7.82	0.00	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	168.55	26.39	3.40	0.85	0.85	2.55
placenta, adult, pool1	10021-101D3	99.33	11.50	4.41	0.22	0.54	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	3.58	3.31	0.13	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	36.73	10.89	1.40	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	53.79	11.02	7.66	0.00	0.00	0.17
postcentral gyrus, adult, pool1	10032-101E5	29.90	11.16	3.23	0.00	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	246.78	14.64	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	324.97	11.02	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	234.72	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	137.65	29.42	5.83	0.44	0.44	1.17
prostate cancer cell line:PC-3	10439-106E7	54.09	14.34	0.36	0.18	0.36	0.36
prostate, adult, pool1	10022-101D4	125.79	22.94	2.45	0.09	0.73	0.45
putamen, adult, donor10196	10176-103C5	62.79	15.34	4.25	0.47	0.00	0.71
putamen, adult, donor10252	10152-102I8	52.94	7.84	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	124.58	4.37	4.37	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	53.64	13.05	4.83	0.00	0.24	0.24
putamen, newborn, donor10223	10365-105F5	57.72	9.00	3.75	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	34.62	4.65	0.58	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	247.60	26.43	8.35	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	57.88	15.90	1.48	0.00	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	104.80	30.24	0.41	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	202.87	25.45	7.95	0.60	0.40	0.89
retinoblastoma cell line:Y79	10475-106I7	2.60	4.16	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	56.06	8.98	2.34	0.25	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	20.81	1.12	1.97	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	143.23	12.88	1.52	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	106.50	14.08	0.65	0.32	0.49	0.00
salivary acinar cells, donor2	11772-123I8	84.13	15.42	0.96	1.24	0.14	0.41
salivary acinar cells, donor3	11773-123I9	82.09	9.27	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	72.07	17.16	0.57	0.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	261.62	20.74	8.43	0.67	0.67	1.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	210.77	20.69	7.41	0.47	0.94	1.18
seminal vesicle, adult	10201-103F3	60.84	15.87	0.53	0.53	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.79	5.34	0.00	0.73	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	217.91	36.99	5.79	0.50	1.51	1.76
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	99.35	28.10	3.01	1.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	361.86	15.31	8.19	0.40	1.07	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	126.11	10.28	4.64	0.11	0.44	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	23.87	5.03	0.65	0.13	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	4.97	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	54.81	6.48	1.80	0.00	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	99.50	16.08	1.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	244.27	13.57	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	173.59	31.56	2.52	0.00	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	43.02	19.68	2.67	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	42.55	17.02	2.52	1.26	0.95	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	100.04	44.52	1.35	0.96	0.77	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	40.38	15.33	1.32	0.00	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	59.84	44.39	0.64	0.16	0.48	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	127.48	15.69	8.28	0.44	0.87	0.22
small intestine, adult, pool1	10024-101D6	89.94	11.47	2.51	0.00	0.36	0.36
small intestine, fetal, donor1	10064-101I1	76.41	10.32	1.72	0.25	0.74	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	12.31	3.59	0.51	0.51	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	129.49	24.55	3.10	0.52	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	89.52	15.01	3.75	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	91.30	21.56	2.75	0.46	0.92	0.23
spinal cord, adult, donor10252	10159-103A6	91.47	14.98	1.97	1.18	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	56.04	3.46	2.77	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	195.76	43.91	8.54	1.22	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	45.00	8.73	0.92	0.46	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	165.34	17.33	4.93	0.45	0.15	0.15
spleen, adult, pool1	10025-101D7	49.12	12.22	0.55	0.33	0.22	0.22
spleen, fetal, pool1	10044-101F8	71.35	13.27	1.27	0.24	0.32	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.93	0.93	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.63	6.08	0.38	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	94.70	13.63	2.10	0.35	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.80	5.08	0.39	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	142.72	12.49	7.09	0.79	0.00	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	91.07	33.89	4.24	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	143.00	19.46	8.88	0.00	0.00	0.42
stomach, fetal, donor1	10062-101H8	67.28	13.88	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	84.31	26.77	0.57	0.57	2.28	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	103.85	19.73	4.15	0.42	0.62	0.62
substantia nigra, adult, donor10258	10371-105G2	34.14	8.28	2.07	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	99.63	13.42	4.95	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	72.91	25.68	1.38	0.46	0.46	0.69
temporal lobe, adult, pool1	10031-101E4	38.66	11.44	4.75	0.17	0.17	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	98.29	49.15	15.67	0.00	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	84.83	32.53	16.70	1.32	2.20	0.00
tenocyte, donor1	11763-123H8	273.35	16.76	6.63	3.14	1.05	2.79
tenocyte, donor2	11765-123I1	329.24	17.93	7.63	3.05	2.29	1.14
tenocyte, donor3	11768-123I4	341.38	12.60	7.78	3.71	3.34	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	358.45	21.42	19.21	1.87	1.87	2.55
teratocarcinoma cell line:NCR-G1	10798-110I6	76.00	14.34	1.08	0.31	0.15	0.46
teratocarcinoma cell line:PA-1	10807-111A6	130.65	19.99	5.27	0.31	0.15	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	318.64	16.25	12.06	1.40	0.51	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	339.98	19.29	16.64	1.13	2.27	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	224.34	11.12	7.96	0.76	0.76	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	263.49	16.61	10.42	2.61	3.26	1.95
testis, adult, pool1	10026-101D8	209.81	33.29	7.95	0.43	1.93	1.29
testis, adult, pool2	10096-102C6	184.49	26.16	9.02	0.00	2.71	0.45
thalamus - adult, donor10196	10168-103B6	41.95	6.62	0.00	0.00	2.21	1.10
thalamus, adult, donor10252	10154-103A1	73.61	14.53	2.34	0.31	0.63	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	63.12	7.70	6.16	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	52.54	15.15	1.48	0.16	1.65	1.15
thalamus, newborn, donor10223	10366-105F6	190.43	23.59	21.86	0.58	0.00	0.58
throat, adult	10209-103G2	150.80	13.73	3.99	1.50	1.00	0.00
throat, fetal, donor1	10061-101H7	60.33	14.63	1.22	0.30	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	3.58	8.35	0.20	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	131.43	40.66	5.77	0.70	1.09	0.50
thymus, fetal, pool1	10043-101F7	91.02	24.83	2.91	0.31	0.42	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	159.02	16.35	4.79	0.40	0.27	1.73
thyroid carcinoma cell line:TCO-1	10783-110G9	83.81	12.29	0.84	0.70	0.14	0.14
thyroid, adult, pool1	10028-101E1	86.31	25.10	3.36	0.47	0.65	0.28
thyroid, fetal, donor1	10060-101H6	60.64	15.03	0.26	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	86.23	9.24	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	97.68	12.33	2.09	0.47	0.47	1.86
tongue, fetal, donor1	10059-101H5	66.21	11.82	1.18	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	66.82	13.22	1.60	0.20	0.10	0.20
trachea, adult, pool1	10029-101E2	75.50	12.52	1.64	0.00	0.33	0.33
trachea, fetal, donor1	10058-101H4	90.02	15.00	0.38	1.54	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	267.48	20.90	9.92	1.06	1.06	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	138.90	25.33	5.57	0.30	0.20	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	150.73	28.36	3.45	0.63	0.78	0.94
tridermal teratoma cell line:HGRT	10694-109G1	89.42	17.12	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	82.36	17.44	2.12	0.25	0.25	0.25
umbilical cord, fetal, donor1	10057-101H3	68.85	18.78	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	150.49	24.06	2.73	0.17	0.85	0.68
uterus, fetal, donor1	10055-101H1	83.96	26.11	1.02	0.00	1.02	0.00
vagina, adult	10204-103F6	154.44	16.80	1.94	0.65	0.00	0.00
vein, adult	10191-103E2	144.45	19.51	1.53	0.22	0.88	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1.87	1.34	0.00	0.00	0.00	0.00